Free Trial

Terence Flynn Analyst Performance

Analyst at The Goldman Sachs Group

Terence Flynn is a stock analyst at The Goldman Sachs Group in the healthcare sector, covering 25 publicly traded companies. Over the past year, Terence Flynn has issued 94 stock ratings, including buy, hold, and sell recommendations. While full access to Terence Flynn's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Terence Flynn's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
158 Last 11 Years
Buy Recommendations
55.10% 81 Buy Ratings
Companies Covered
25 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy55.1%80 ratings
Hold40.8%60 ratings
Sell4.1%5 ratings

Out of 147 total stock ratings issued by Terence Flynn at The Goldman Sachs Group, the majority (55.1%) have been Buy recommendations, followed by 40.8% Hold and 4.1% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
64.0% of companies on NASDAQ
16 companies
NYSE
36.0% of companies on NYSE
9 companies

Terence Flynn, an analyst at The Goldman Sachs Group, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
25 companies
100.0%

Terence Flynn of The Goldman Sachs Group specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
16 companies
64.0%
PHARMACEUTICALS
9 companies
36.0%

Terence Flynn's Ratings History at The Goldman Sachs Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Amgen Inc. stock logo
AMGN
Amgen
11/4/2026Boost Price Target$477.85$410.00Equal Weight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
11/4/2026Lower Price Target$90.51$106.00Overweight
Biohaven Ltd. stock logo
BHVN
Biohaven
11/3/2026Boost Price Target$15.35$21.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
11/3/2026Lower Price Target$533.28$660.00Overweight
AbbVie Inc. stock logo
ABBV
AbbVie
11/2/2026Boost Price Target$288.68$346.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
10/30/2026Boost Price Target$1,425.08$1,596.00Overweight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
10/30/2026Lower Price Target$62.91$40.00Underweight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
10/15/2026Lower Price Target$255.89$292.00Overweight
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
10/7/2026Boost Price Target$56.96$67.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
10/7/2026Boost Price Target$1,181.88$1,430.00Overweight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
10/7/2026Reiterated Rating$59.60$41.00Underweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
10/7/2026Lower Price Target$94.90$114.00Overweight
AbbVie Inc. stock logo
ABBV
AbbVie
10/7/2026Boost Price Target$271.69$310.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
10/7/2026Lower Price Target$413.05$359.00Equal Weight
Moderna, Inc. stock logo
MRNA
Moderna
10/7/2026Boost Price Target$191.22$95.00Equal Weight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
10/7/2026Lower Price Target$143.42$177.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
10/7/2026Boost Price Target$553.69$566.00Equal Weight
Alumis Inc. stock logo
ALMS
Alumis
9/2/2026Lower Price Target$9.47$29.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
9/1/2026Initiated Coverage$547.65$665.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
8/21/2026Boost Price Target$151.90$160.00Buy
Moderna, Inc. stock logo
MRNA
Moderna
8/20/2026Boost Price Target$174.38$89.00Equal Weight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
8/20/2026Upgrade$152.21$179.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
8/19/2026Reiterated Rating$440.44$362.00Overweight
Biohaven Ltd. stock logo
BHVN
Biohaven
8/12/2026Boost Price Target$14.43$19.00Overweight
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
8/10/2026Set Price Target$28.66$23.00
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
8/6/2026Reiterated Rating$57.75$65.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
8/6/2026Set Price Target$515.12$515.00
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
8/6/2026Reiterated Rating$1,170.30$1,419.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
8/5/2026Boost Price Target$390.63$351.00Equal Weight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
8/5/2026Boost Price Target$147.06$116.00Equal Weight
AbbVie Inc. stock logo
ABBV
AbbVie
8/3/2026Reiterated Rating$245.26$296.00Overweight
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
7/28/2026Boost Price Target$23.43$38.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
7/21/2026Downgrade$510.23Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
7/16/2026Boost Price Target$247.55$294.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
7/9/2026Boost Price Target$124.92$113.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
7/8/2026Boost Price Target$267.35$284.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
7/8/2026Boost Price Target$1,233.32$1,347.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
7/8/2026Lower Price Target$93.86$119.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
7/8/2026Lower Price Target$203.56$222.00Equal Weight
Amgen Inc. stock logo
AMGN
Amgen
7/8/2026Lower Price Target$367.11$333.00Equal Weight
Today's free pick (on me) (Ad)

Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel

Get today's free pick before December 8th.
Amgen Inc. stock logo
AMGN
Amgen
6/9/2026Boost Price Target$344.57$340.00Equal Weight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
6/5/2026Reiterated Rating$1,146.74Overweight
Alumis Inc. stock logo
ALMS
Alumis
5/15/2026Reiterated Rating$24.06$39.00Overweight
Biohaven Ltd. stock logo
BHVN
Biohaven
5/13/2026Lower Price Target$8.97$18.00Overweight
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
5/11/2026Boost Price Target$25.61$22.00Equal Weight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
5/7/2026Set Price Target$580.95$516.00
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
5/5/2026Boost Price Target$418.09$616.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
5/1/2026Reiterated Rating$961.47$1,344.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
5/1/2026Set Price Target$326.04$332.00
AbbVie Inc. stock logo
ABBV
AbbVie
4/30/2026Boost Price Target$211.67$278.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
4/28/2026Boost Price Target$343.85$326.00Equal Weight
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
4/27/2026Boost Price Target$13.22$15.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4/15/2026Set Price Target$238.02$283.00
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
4/10/2026Boost Price Target$47.87$63.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
4/10/2026Boost Price Target$569.04$519.00Equal Weight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
4/10/2026Boost Price Target$437.02$612.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
4/10/2026Boost Price Target$93.13$126.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
4/10/2026Boost Price Target$354.48$326.00Equal Weight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4/10/2026Boost Price Target$939.18$1,327.00Overweight
Pfizer Inc. stock logo
PFE
Pfizer
4/10/2026Boost Price Target$27.02$28.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4/10/2026Boost Price Target$239.90$267.00Overweight
Alumis Inc. stock logo
ALMS
Alumis
3/20/2026Boost Price Target$25.38$38.00Overweight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
3/18/2026Set Price Target$237.17$253.00
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
3/18/2026Reiterated Rating$237.60Overweight
Pfizer Inc. stock logo
PFE
Pfizer
3/17/2026Set Price Target$27.10$27.00Positive
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/10/2026Lower Price Target$83.60$125.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
3/10/2026Boost Price Target$499.41$596.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
3/5/2026Reiterated Rating$986.00$1,313.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/13/2026Reiterated Rating$495.48$570.00Overweight
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
2/12/2026Reiterated Rating$44.23$61.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
2/8/2026Set Price Target$201.18$190.00
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2/6/2026Reiterated Rating$61.43$40.00Underweight
AbbVie Inc. stock logo
ABBV
AbbVie
2/5/2026Boost Price Target$217.04$270.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2/5/2026Boost Price Target$1,107.13$1,313.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
2/4/2026Boost Price Target$338.59$309.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
1/22/2026Boost Price Target$219.82$200.00Equal Weight
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
1/8/2026Reiterated Rating$23.19$20.00Equal Weight
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
1/8/2026Upgrade$18.49$36.00Overweight
Alumis Inc. stock logo
ALMS
Alumis
1/7/2026Boost Price Target$16.23$33.00Overweight
Biohaven Ltd. stock logo
BHVN
Biohaven
1/6/2026Lower Price Target$9.47$21.00Overweight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
12/12/2025Boost Price Target$210.42$197.00Equal Weight
Pfizer Inc. stock logo
PFE
Pfizer
12/12/2025Lower Price Target$25.90$28.00Equal Weight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
12/12/2025Reiterated Rating$51.16$37.00Underweight
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
12/12/2025Boost Price Target$66.60$125.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
12/12/2025Boost Price Target$173.12$156.00Equal Weight
Amgen Inc. stock logo
AMGN
Amgen
12/12/2025Lower Price Target$315.74$304.00Equal Weight
AbbVie Inc. stock logo
ABBV
AbbVie
12/12/2025Boost Price Target$222.00$269.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
12/12/2025Boost Price Target$99.54$102.00Equal Weight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
12/5/2025Set Price Target$461.18$564.00
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
12/3/2025Upgrade$433.15$516.00Overweight
Why I'm selling my Snapback Indicator for just $7 (Ad)

For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel

Get lifetime access to the Snapback Indicator for a one-time $7 payment today.
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
12/2/2025Boost Price Target$100.74$120.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
11/24/2025Boost Price Target$1,058.05$1,290.00Overweight
Biohaven Ltd. stock logo
BHVN
Biohaven
11/18/2025Lower Price Target$9.58$26.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
11/13/2025Boost Price Target$1,018.28$1,171.00Overweight
Organon & Co. stock logo
OGN
Organon & Co.
11/11/2025Lower Price Target$7.73$9.00Equal Weight
Biohaven Ltd. stock logo
BHVN
Biohaven
11/5/2025Reiterated Rating$8.42Overweight
Amgen Inc. stock logo
AMGN
Amgen
11/5/2025Lower Price Target$296.70$329.00Equal Weight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
11/3/2025Reiterated Rating$103.96$134.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
11/3/2025Boost Price Target$83.42$100.00Equal Weight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
10/31/2025Lower Price Target$146.77$92.00
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
10/15/2025Set Price Target$190.88$190.00
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/14/2025Lower Price Target$9.17$15.00Equal Weight
Pfizer Inc. stock logo
PFE
Pfizer
10/10/2025Lower Price Target$25.08$32.00Equal Weight
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
10/10/2025Lower Price Target$36.06$54.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
10/10/2025Lower Price Target$104.48$131.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
10/10/2025Boost Price Target$443.68$435.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
10/10/2025Boost Price Target$191.29$178.00Equal Weight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
10/3/2025Lower Price Target$820.69$1,023.00Overweight
Alumis Inc. stock logo
ALMS
Alumis
8/15/2025Lower Price Target$4.39$22.00Overweight
Biohaven Ltd. stock logo
BHVN
Biohaven
8/12/2025Lower Price Target$13.42$54.00Overweight
Pfizer Inc. stock logo
PFE
Pfizer
8/6/2025Boost Price Target$23.96$33.00Equal Weight
Amgen Inc. stock logo
AMGN
Amgen
8/6/2025Boost Price Target$284.41$333.00Equal Weight
AbbVie Inc. stock logo
ABBV
AbbVie
8/1/2025Boost Price Target$193.55$255.00Overweight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
7/31/2025Reiterated Rating$43.37Hold
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
7/17/2025Boost Price Target$164.78$176.00Equal Weight
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
7/15/2025Set Price Target$12.69$16.00Equal Weight
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
7/10/2025Boost Price Target$36.18$54.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
7/10/2025Boost Price Target$112.29$133.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
7/10/2025Reiterated Rating$792.63$1,135.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
7/10/2025Lower Price Target$84.40$98.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
7/10/2025Boost Price Target$157.81$171.00Equal Weight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
7/10/2025Lower Price Target$48.17$34.00Underweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
7/10/2025Lower Price Target$301.15$328.00Equal Weight
Arvinas, Inc. stock logo
ARVN
Arvinas
5/9/2025Lower Price Target$6.69$11.00Equal Weight
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
5/9/2025Lower Price Target$8.46$22.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
5/6/2025Lower Price Target$99.33$132.00Overweight
Organon & Co. stock logo
OGN
Organon & Co.
5/5/2025Lower Price Target$8.82$10.00Equal Weight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
5/1/2025Boost Price Target$296.52$348.00Equal Weight
AbbVie Inc. stock logo
ABBV
AbbVie
4/28/2025Boost Price Target$185.96$250.00Overweight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4/16/2025Boost Price Target$154.80$169.00Equal Weight
Organon & Co. stock logo
OGN
Organon & Co.
4/9/2025Lower Price Target$11.32$15.00Equal Weight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4/9/2025Lower Price Target$702.91$1,124.00Overweight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4/9/2025Boost Price Target$146.25$164.00Equal Weight
AbbVie Inc. stock logo
ABBV
AbbVie
4/9/2025Boost Price Target$167.66$241.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
4/9/2025Boost Price Target$272.28$330.00Equal Weight
Arvinas, Inc. stock logo
ARVN
Arvinas
3/13/2025Lower Price Target$8.58$12.00Equal Weight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/11/2025Lower Price Target$100.97$139.00Overweight
Biohaven Ltd. stock logo
BHVN
Biohaven
3/7/2025Lower Price Target$30.08$63.00Overweight
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
2/18/2025Lower Price Target$11.00$25.00Overweight
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/14/2025Boost Price Target$43.49$32.00Underweight
Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel

See the five stocks Weiss Ratings analysts are watching closely now.
Organon & Co. stock logo
OGN
Organon & Co.
2/14/2025Lower Price Target$16.17$16.00Equal Weight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2/5/2025Lower Price Target$90.99$106.00Equal Weight
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
2/3/2025Boost Price Target$19.71$17.00Equal Weight
AbbVie Inc. stock logo
ABBV
AbbVie
2/3/2025Boost Price Target$188.39$239.00Overweight
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
1/27/2025Downgrade$10.99$11.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
1/23/2025Lower Price Target$146.82$163.00Equal Weight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
1/21/2025Lower Price Target$96.46$113.00Equal Weight